A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?

Kidney Int. 2021 Oct;100(4):937-938. doi: 10.1016/j.kint.2021.07.026. Epub 2021 Aug 17.

Authors

Miguel Villa¹, Francisco Díaz-Crespo², Ana Pérez de José³, Úrsula Verdalles³, Eduardo Verde³, Fernando Almeida Ruiz², Adriana Acosta³, Antonia Mijaylova³, Marian Goicoechea³

Affiliations

¹ Nephrology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: [email protected].
² Pathology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
³ Nephrology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / chemically induced
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines
ChAdOx1 nCoV-19